Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duraphat Fluoride Varnish is a topical dental preparation containing 5% w/v sodium fluoride (50 mg/mL), equivalent to 22,600 ppm (22.6 mg) of fluoride ion per mL in an alcoholic solution of natural resins[1][2][3][4]. It is applied professionally to the teeth as a thin layer for the prevention of dental caries and for the desensitization of hypersensitive teeth. The mechanism involves formation of calcium fluoride globules on tooth surfaces; these act as a reservoir that slowly releases fluoride ions, promoting remineralization and inhibiting demineralization by cariogenic acids[2][3]. The product is indicated for both children and adults as part of comprehensive caries control programs or treatment regimens for dentine hypersensitivity. It should be applied by dental professionals only.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on duraphat fluoride varnish.